Found 9 matching trials
A Study to Evaluate Safety, Immunogenicity, and Lot-to-Lot Consistency of H5N1 Subunit Influenza Virus Vaccine in Healthy Adult Subjects ≥18 Years of Age PHASE3 This Phase 3 study evaluates the safety, immunogenicity and lot-to lot cons...
Show More Location
Optimal Research, LLC
Learn More & Join Trial
Evaluating Safety and Immune Response to the HIV-1 CH505 Transmitted/Founder gp120 Adjuvanted With GLA-SE in Healthy, HIV-exposed Uninfected Infants PHASE1 This study evaluated the safety and immune response in healthy HIV-exposed ...
Show More Location
Perinatal HIV Research Unit (PHRU), Soweto CRS
Learn More & Join Trial
Combination Study With MVA BN and Dryvax PHASE1 The overall goals of this study are to expand the available data on the saf...
Show More Location
Saint Louis University
Learn More & Join Trial
Progesterone Amplifies Estrogen-stimulated Growth Hormone Secretion in Older Women PHASE1 Progesterone amplifies estrogen-stimulated Growth Hormone (GH) secretion in...
Show More Location
Mayo Clinic in Rochester
Learn More & Join Trial
Multimodal Pain Management for Cesarean Delivery PHASE4 Opioid use and abuse has become a major medical problem in the United State...
Show More Location
University of Texas Medical Branch
Learn More & Join Trial
A Study to Evaluate Safety and Immunogenicity of One or Two Booster Vaccinations With H5N6 Influenza Vaccine in Adults Primed With H5N1 Influenza Vaccine or Unprimed PHASE2 This is a Phase 2, randomized, multi-center study in approximately 300 adul...
Show More Location
Optimal Research, LLC
Learn More & Join Trial
Safety and Immunogenicity of Recombinant RSV Vaccine (CHO Cell) in Healthy Subjects Aged 18 Years and Above PHASE1 The purpose of this study is to assess the safety and immunogenicity of two...
Show More Status
Active Not Recruiting
Location
Liangyuan District Center for Disease Prevention and Control
Learn More & Join Trial
Safety & Immunogenicity of 426c.Mod.Core-C4b Vaccine With 3M-052-AF+Alum in Infants Perinatally Exposed to HIV But Uninfected PHASE1 The purpose of this study is to evaluate the safety and immunogenicity of 4...
Show More Learn More & Join Trial
SHIELD-T1D: Shingrix and GLP-1 Agonist for Beta-Cell Preservation in Recent-Onset Type 1 Diabetes. PHASE2 Type 1 diabetes (T1D) is a chronic autoimmune disease characterized by prog...
Show More Location
Ministry of Health Medical City
Learn More & Join Trial